- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 765049
Total 1219 results
-
Boehringer IngelheimRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Gastrointestinal Cancer | Liver CancerJapan
-
Boehringer IngelheimRecruitingColorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal NeoplasmsUnited States, Canada
-
Boehringer IngelheimRecruitingMyocardial InfarctionGermany, Spain, Hungary, United Kingdom, Canada, Australia, Poland, Slovakia, Italy, New Zealand, Korea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruitingMelanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)Netherlands
-
Boehringer IngelheimRecruitingNeoplasmsSpain, United States, Belgium, Japan, Netherlands, Italy
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
OSE ImmunotherapeuticsBoehringer IngelheimActive, not recruitingSolid Tumor, AdultFrance, Belgium
-
Boehringer IngelheimActive, not recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Spain, United States, United Kingdom, France, Thailand, Malaysia, Mexico, Romania, Poland, Japan, Moldova, Republic of
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...RecruitingSystemic Lupus ErythematosusUnited States, Spain, China, Korea, Republic of, Argentina, Bulgaria, Chile, Greece, Japan, Mauritius, Mexico, Moldova, Republic of, Poland, South Africa, Australia, Colombia, Philippines, Serbia
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimWithdrawnAnal Canal Squamous Cell CarcinomaKorea, Republic of
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedNeoplasms | Carcinoma, Non-Small-Cell LungUnited States, Spain, United Kingdom, Canada, Poland
-
Boehringer IngelheimTerminatedNeoplasms | Carcinoma, Non-Small-Cell Lung | Neoplasm MetastasisUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCoronavirus Disease 2019United States, Brazil, Philippines
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Netherlands
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimRecruitingSolid TumorsSpain, Japan, United Kingdom, United States
-
Boehringer IngelheimCompletedNeoplasmsSpain, United States, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruiting